Drug Profile
Amoxicillin+Clarithromycin+Omeprazole co-packaged - Par Pharmaceuticals
Alternative Names: Omeclamox-PakLatest Information Update: 09 May 2019
Price :
$50
*
At a glance
- Originator DAVA Pharmaceuticals
- Developer Currax Pharmaceuticals
- Class 2 pyridinylmethylsulfinylbenzimidazoles; Antibacterials; Antiulcers; Gastric antisecretories; Macrolides; Penicillins; Small molecules
- Mechanism of Action Cell wall inhibitors; Protein 50S ribosomal subunit inhibitors; Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Duodenal ulcer; Helicobacter infections